About
Vildagliptin and Metformin is a fixed-dose combination medication used for the management of type 2 diabetes mellitus. Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances the body's natural ability to control blood glucose by increasing the levels of active incretin hormones (GLP-1 and GIP). These hormones increase insulin synthesis and release from pancreatic beta cells and decrease glucagon secretion from alpha cells. Metformin, a biguanide, primarily reduces hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
This dual mechanism of action provides comprehensive glycemic control, addressing both insulin resistance and impaired insulin secretion, making it an effective option for patients whose diabetes is not adequately controlled by metformin alone or other therapies.
Uses
- Treatment of type 2 diabetes mellitus.
- Improvement of glycemic control.
- When diet and exercise alone are insufficient.
- As an add-on to other antidiabetic agents.
Directions For Use
Take this medication orally, usually twice daily with meals, or as prescribed by your doctor. Swallow tablets whole.
Benefits
- Provides dual mechanism of action for comprehensive control.
- Significantly lowers HbA1c levels.
- Low risk of hypoglycemia when used alone.
- May lead to modest weight loss or be weight-neutral.
- Improves both fasting and postprandial glucose levels.
- Convenient fixed-dose combination.
Side Effects
- Nausea
- Diarrhea
- Abdominal pain
- Headache
- Dizziness
- Nasopharyngitis
- Tremor
- Fatigue
- Hypoglycemia (when combined with sulfonylureas/insulin)
- Lactic acidosis (rare, due to metformin)
- Vitamin B12 deficiency (long-term metformin use)
- Pancreatitis (rare, due to vildagliptin)
Safety Measures
- Alcohol - Avoid excessive alcohol intake, especially with metformin, due to an increased risk of lactic acidosis.
- Pregnancy - Not recommended during pregnancy. Consult your doctor, as alternative treatments may be safer.
- Breastfeeding - Metformin is excreted in breast milk; vildagliptin's excretion is unknown. Use with caution; consult a healthcare professional.
- Liver - Contraindicated in severe liver impairment due to the metformin component. Vildagliptin requires caution.
- Kidney - Contraindicated in severe kidney impairment (eGFR <30 mL/min/1.73m²) due to metformin. Dosage adjustment needed for moderate impairment.
- Lung - Generally safe for use in patients with lung conditions; however, severe respiratory failure can increase lactic acidosis risk with metformin.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!